transdermal ozone associated with ~59–72% reduction in viral load markers over 6 months
Ozone therapy reduced HCV viral load (PCR quantitative) by approximately 59% after 2 months and 72% after 6 months of treatment in patients with HCV genotype 4.
What this means for you
When the body's oxidative environment shifts, immune and antiviral responses can become more active. A measurable drop in viral load markers over time suggests ozone exposure may support the body's own defenses — something worth understanding if you're focused on immune resilience and long-term wellness.
The published research
OZONE THERAPY IN PATIENTS
This page describes a documented finding about the underlying wellness technology. It is not a marketing claim about any specific device. For information about HOCATT specifically, visit hocatt.com.